Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Sickle cell nephropathy is a known complication of sickle cell anemia (SCA) manifested by increase in glomerular filtration rate (glomerular hyperfiltration) and results in proteinuria and chronic renal failure. Our goal is to examine the prevalence of proteinuria and microalbuminuria as an early predictive factor of glomerular injury, among young people who suffer from SCA as well as those who suffer from combined sickle cell/beta-thalassemia.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2010
CompletedFirst Posted
Study publicly available on registry
March 24, 2010
CompletedMarch 24, 2010
March 1, 2010
March 23, 2010
March 23, 2010
Conditions
Study Arms (1)
Sickle cell beta
Interventions
Eligibility Criteria
Young people suffering from SCA as well as those who suffer from combined sickle cell/beta-thalassemia, between 0-25 years old.
You may qualify if:
- Patients diagnosed with sickle cell anemia
- Patients diagnosed with combined sickle cell anemia/beta-thalassemia
You may not qualify if:
- Diabetes mellitus
- Hypertension
- Reduced renal mass (single kidney)
- Overweight
- History of UTIs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
March 23, 2010
First Posted
March 24, 2010
Last Updated
March 24, 2010
Record last verified: 2010-03